Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.26B | 1.34B | 2.02B | 2.81B | 1.68B | 836.42M |
Gross Profit | 246.55M | 274.25M | 450.41M | 627.69M | 375.00M | 202.73M |
EBITDA | -387.00K | 3.99M | 129.34M | 285.14M | 152.35M | 2.41M |
Net Income | -17.74M | -14.56M | 72.63M | 188.46M | 132.00M | -12.14M |
Balance Sheet | ||||||
Total Assets | 576.24M | 589.25M | 679.32M | 947.84M | 732.81M | 356.97M |
Cash, Cash Equivalents and Short-Term Investments | 80.70M | 81.63M | 17.09M | 3.60M | 1.04M | 1.60M |
Total Debt | 3.31M | 3.87M | 5.27M | 157.75M | 195.49M | 73.15M |
Total Liabilities | 158.03M | 170.29M | 205.92M | 490.62M | 435.28M | 202.06M |
Stockholders Equity | 418.21M | 418.96M | 473.39M | 457.22M | 297.53M | 154.38M |
Cash Flow | ||||||
Free Cash Flow | 111.40M | 111.40M | 234.52M | 125.26M | -92.79M | 22.59M |
Operating Cash Flow | 119.79M | 120.12M | 248.50M | 134.05M | -85.62M | 27.20M |
Investing Cash Flow | -8.39M | -8.71M | -13.78M | -43.87M | -34.05M | -4.62M |
Financing Cash Flow | -35.92M | -46.85M | -221.24M | -87.60M | 119.09M | -22.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | $1.01B | 98.87 | 2.28% | ― | 5.17% | -65.33% | |
64 Neutral | $764.87M | 29.04 | 11.28% | ― | 30.04% | 43.47% | |
52 Neutral | $420.94M | ― | -1.96% | ― | -29.16% | -140.16% | |
51 Neutral | $7.39B | 0.40 | -62.86% | 2.37% | 15.56% | -1.99% | |
51 Neutral | $758.92M | 77.26 | 42.49% | ― | 9.05% | ― | |
48 Neutral | $37.18M | ― | -951.52% | ― | -0.70% | -2.38% | |
45 Neutral | $669.60M | 18.62 | -21.08% | ― | -18.13% | -215.78% |
Cross Country Healthcare announced its financial results for the first quarter of 2025, showing a consolidated revenue of $293.4 million, which represents a 23% decrease year-over-year. Despite the decline in revenue, the company reported growth in its Homecare and Physician Staffing segments, with double-digit revenue increases. The company maintained a strong balance sheet with $81 million in cash and no debt as of March 31, 2025. The company is also in the process of a merger with Aya Healthcare, expected to be completed in the second half of the year.